Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kouji Oohashi is active.

Publication


Featured researches published by Kouji Oohashi.


Archive | 2010

Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase)-inhibitory peptide, and use of the peptide

Shin-Ichiro Hirai; Tokiyoshi Matsushita; Yukie Fujita; Hiroaki Kurashima; Kouji Oohashi


Archive | 2010

Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide

Shin-Ichiro Hirai; Tokiyoshi Matsushita; Yukie Fujita; Hiroaki Kurashima; Kouji Oohashi


Archive | 2006

Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active Ingredient

Kouji Oohashi; Reina Doi; Masaaki Kageyama


Archive | 2006

Angiogenesis Inhibitor Containing Amine Derivative as Active Ingredient

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama


Archive | 2011

イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の予防または治療方法、イソキノリンスルホニル誘導体またはその医薬的に許容される塩、ならびにその使用

Kouji Oohashi; 康司 大橋; Shinichiro Hirai; 平井 慎一郎; Masaaki Kageyama; 景山 正明; Kenichi Endo; 健一 遠藤


Archive | 2011

Method of treating retinal vein occlusion

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama


Archive | 2011

Method of treating diabetic retinopathy

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama


Archive | 2011

Prophylactic or therapeutic agent for retinal/choroidal denaturation diseases comprising isoquinolinesulfonyl derivative as active ingredient, prophylactic or therapeutic method for retinal/choroidal denaturation diseases, and isoquinolinesulfonyl derivative or pharmaceutically acceptable salt thereof and use thereof

Kouji Oohashi; 康司 大橋; Shinichiro Hirai; 平井 慎一郎; Masaaki Kageyama; 景山 正明; Kenichi Endo; 健一 遠藤


Archive | 2010

JNK(c-Junアミノ末端キナーゼ)阻害ペプチドを用いた網膜疾患の予防または治療剤、網膜疾患の予防または治療方法、ならびに、その使用

Shinichiro Hirai; 平井 慎一郎; Tokiyoshi Matsushita; 登起義 松下; Yukie Fujita; 由紀恵 藤田; Hiroaki Kurashima; 宏明 倉島; Kouji Oohashi; 康司 大橋


Archive | 2006

Ein aminderivat als wirkstoff enthaltender angiogeneseinhibitor An amine derivative containing as active ingredient angiogenesis inhibitor

Kouji Oohashi; Reina Doi; Tatsuji Kurose; Masaaki Kageyama

Collaboration


Dive into the Kouji Oohashi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Reina Doi

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Tatsuji Kurose

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yukie Fujita

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Shinichiro Hirai

National Archives and Records Administration

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge